Intellia Therapeutics Cash from Investing (TTM) Trends

Intellia Therapeutics Inc (NTLA)

23.60 +0.33 (+1.42%) USD | NASDAQ | May 03, 16:00

23.59 -0.01 (-0.04%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	-31.35M
September 30, 2023	-107.44M
June 30, 2023	-139.30M
March 31, 2023	-9.412M
December 31, 2022	160.31M
September 30, 2022	31.35M
June 30, 2022	-415.68M
March 31, 2022	-477.76M
December 31, 2021	-550.78M
September 30, 2021	-602.58M
June 30, 2021	-357.18M
March 31, 2021	-297.48M
December 31, 2020	-214.49M
September 30, 2020	24.32M
June 30, 2020	146.64M
March 31, 2020	76.93M
December 31, 2019	25.18M

Date	Value
September 30, 2019	-258.72M
June 30, 2019	-229.09M
March 31, 2019	-253.24M
December 31, 2018	-260.78M
September 30, 2018	-7.163M
June 30, 2018	-7.407M
March 31, 2018	-7.779M
December 31, 2017	-10.09M
September 30, 2017	-11.10M
June 30, 2017	-9.444M
March 31, 2017	-9.319M
December 31, 2016	-6.165M
September 30, 2016	-3.609M
June 30, 2016	-3.606M
March 31, 2016	-3.046M
December 31, 2015	-2.554M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-602.58M

Minimum

Sep 2021

160.31M

Maximum

Dec 2022

-169.82M

Average

-139.30M

Median

Jun 2023

Cash from Investing (TTM) Benchmarks